The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

Although the genetic material of most living organisms is DNA, various self-replicating agents rely instead on RNA, including ...

The Department of Health and Human Services had canceled hundreds of millions of dollars in funding previously committed help develop mRNA vaccines.

Sox9, a master regulator of cartilage formation, switches its target genes dynamically during embryonic limb development ...

A new study analyzed piRNA — first discovered in 2006 — as a strong predictor of short-term survival in older patients. It ...

The advent of single-cell omics technologies has revolutionized our understanding of the complex cellular landscape in cancer. Traditional bulk sequencing ...

For many families, eight years of uncertainty meant repeated specialist visits, inconclusive genetic tests and the growing ...

Advances in DNA sequencing technology help forensic biologists identify suspects where traditional DNA profiling has failed, ...

Scientists have uncovered new genetic causes of diabetes in infants, pointing to a region of the genome that has long been ...

Eluciderm, Inc., a clinical-stage pharmaceutical company developing small molecule therapeutics to promote healing and regenerative repair of injured tissue, announced today that it received the Wound ...

Scientists at St. Jude Children's Research Hospital today report how lifesaving childhood cancer treatments leave ...

In this valuable study, the authors develop new approaches to investigate mRNA imprinting, a phenomenon in which RNA-protein complexes form in the nucleus to influence the fate of transcripts in the ...